European journal of cancer & clinical oncology

other 1988

Stimulation by caffeine of spontaneous mammary tumorigenesis in mice

doi:10.1016/0277-5379(88)90322-7 ·PMID:3383984

nonrandomized-trial 1988

Therapeutic efficacy of danazol in myelodysplastic syndromes

doi:10.1016/0277-5379(88)90339-2 ·PMID:3181270

Sixteen unselected untreated patients with primary myelodysplastic syndromes (MDS) and various combinations of blood cytopenia were treated with danazol, an attenuated androgen reported to be of some value in these conditions. After a 12 we…

rct 1985

Antagonism of aminoglutethimide and danazol in the suppression of serum free oestradiol in breast cancer patients

doi:10.1016/0277-5379(85)90292-5 ·PMID:4065179

The response rate of advanced postmenopausal breast cancer patients to treatment with aminoglutethimide (AG) + danazol was significantly worse than that with AG alone. The suppression of serum oestradiol levels by AG + danazol was similar t…

nonrandomized-trial 1985

Endocrine treatment with anti-estrogen, anti-androgen or progestagen of advanced malignant melanoma: three consecutive phase II trials

doi:10.1016/0277-5379(85)90010-0 ·PMID:2934258

Malignant melanoma is generally considered as a hormone-independent tumour. However, epidemiological, clinical and experimental data suggest that steroid hormones can influence the growth of this tumour. The therapeutic efficacy of endocrin…

lab-animal 1985

Suppression of normal and preneoplastic mammary growth and uterine adenomyosis with reduced growth hormone level in SHN mice given monosodium glutamate neonatally

doi:10.1016/0277-5379(85)90250-0 ·PMID:3830732

As a step in the evaluation of the role of growth hormone (GH) in mammary tumorigenesis, the effects of neonatal treatment with monosodium glutamate (MSG) on normal and neoplastic mammary growth, plasma levels of GH and prolactin (PRL) and …